What Blue Cross Laboratories does

Blue Cross Laboratories Pvt. Ltd. is an India-based, privately held research-based pharmaceutical company founded in 1980 by chairman Mr. N.H. Israni, headquartered in Mumbai with WHO-GMP-certified manufacturing facilities in Nashik (established 1983) and Goa (established 1995). The company develops, manufactures, and distributes affordable generic pharmaceutical formulations across multiple therapeutic segments — analgesics, anti-bacterials (including a dedicated Cephalosporin unit), anti-diabetics, antipyretics, antispasmodics, cough & cold preparations, gastrointestinal, cardiovascular, dermatologicals, and multivitamins — spanning solid orals, liquid orals, topicals, and injectables. Its 164-product portfolio is organized into three divisions: Blue Cross Division (mass-market brands), Blue Cross Life Sciences Division (chronic-therapy), and Excel Division (acute and specialty). Two flagship brands, MEFTAL (analgesic/antispasmodic) and TUSQ (cough & cold), are household names and rank in the Top 300 of the Indian Pharmaceutical Market, where Blue Cross holds the 33rd position overall.

The company employs approximately 3,400 people and operates a Quality-by-Design R&D model (DSIR-recognized since 2001) with Novel Drug Delivery System capabilities including dispersible, mouth-dissolving, extended-/controlled-release, and emulgel formulations. Blue Cross earns revenue primarily through unit-priced sales of branded generics — both DPCO 2013 price-controlled scheduled drugs (disclosed publicly via Form V circulars) and non-scheduled products priced through its distribution network. Go-to-market is sales-led via a medical field force of representatives and product managers engaging doctors and KOLs, supported by HCP-facing content channels (quarterly Medical Bulletins, Medical Tips / Clinical Insights, Doctors Domain portal, HiDOCTOR digital portal). Distribution runs through a pan-India network of 21 C&F agents and depots feeding 3,500 stockists, plus direct exports from WHO-GMP plants to 15 emerging-market countries across East Africa, Southern Africa, South Asia, and Southeast Asia (Kenya, Tanzania, Uganda, Rwanda, DR Congo, Mauritius, Lesotho, Maldives, South Sudan, Cambodia, Sri Lanka, Myanmar, Nepal). Multiple international regulatory approvals (Pharmacy & Poison Board Kenya, NDA Uganda, DR Congo, Department of Drug Administration Nepal, Medical Stores Organization) and ISO 9001:2015 certification underpin the export franchise, and the company participates in India's Pharmacovigilance Programme (PvPI) for adverse drug reaction reporting.

Name

Blue Cross Laboratories

Legal name

Blue Cross Laboratories Pvt. Ltd.

Website

https://bluecrosslabs.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Blue Cross Laboratories is a privately held Indian pharmaceutical company founded in 1980 that manufactures and distributes affordable generic formulations across 164 SKUs in analgesics, anti-infectives, anti-diabetics, cardiovascular, and respiratory segments, selling through 3,500 Indian stockists and exporting to 15 emerging-market countries from WHO-GMP plants in Nashik and Goa.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Topical & Dermatology Generics (HLAIABAE)

akta.pro secondary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

Keywords

• Generic pharmaceuticals
• Branded formulations
• Pharmaceutical manufacturing
• Prescription medicines
• Drug formulation

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Infrastructure

Revenue model

1. Pharmaceutical Product Sales (Domestic & International): Primary revenue stream from sale of generic pharmaceutical formulations (tablets, syrups, injections, creams, etc.) across therapeutic segments including analgesics, anti-bacterials, anti-diabetics, cough & cold, gastrointestinal, cardiovascular, dermatological, and multivitamins. Distributed domestically through stockists and C&F agents across India and exported to 15 countries.
2. International / Export Business: Export of high-quality generics to international markets across Asia and Africa (Kenya, Tanzania, Uganda, Rwanda, DR Congo, Mauritius, Lesotho, Maldives, South Sudan, Cambodia, Sri Lanka, Myanmar and beyond). Products include liquid, solid, and semi-solid dosage forms from WHO-GMP-certified facilities.
3. DPCO 2013 Regulated Product Sales: Sale of price-controlled products under the Drug Prices Control Order (DPCO) 2013 framework with periodically published price lists (Form V).

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels7 records

Core offering

Blue Cross Laboratories manufactures and distributes generic pharmaceutical formulations (tablets, syrups, suspensions, dry syrups, injections, drops, creams, gels, ointments, lozenges) across major therapeutic areas including analgesics, anti-bacterials, anti-diabetics, antipyretics, antispasmodics, cough & cold preparations, gastrointestinal, cardiovascular, dermatologicals, and multivitamins. Products are organized under three commercial divisions — Blue Cross Division (mass-market branded generics led by MEFTAL and TUSQ), Blue Cross Life Sciences Division (chronic-therapy focused), and Excel Division (acute-therapy and dermatology). The portfolio of 164 products is produced at two WHO-GMP certified manufacturing plants in Nashik and Goa and sold domestically through 3,500 stockists and exported to 15 countries.

Differentiator

Problem solved

Functional benefit

Brands

• MEFTAL: Leading analgesic/antipyretic brand across India and outside India.
• TUSQ
• Blue Cross Division
• Blue Cross Life Sciences Division
• Excel Division

Products and services

• Blue Cross Division Blue Cross's core pharmaceutical division offering mass-market branded generic formulations including flagship brands MEFTAL and TUSQ. Covers analgesics, anti-bacterials, anti-diabetics, antipyretics, antispasmodics, cough & cold preparations, gastrointestinal, and multivitamins & minerals across liquid, solid, and semi-solid dosage forms for retail pharmacy distribution across India.
• Blue Cross Life Sciences Division Specialty pharmaceutical division focused on chronic-therapy areas including anti-diabetics, cardiovascular agents, gastrointestinal, and multivitamins. Targets lifestyle and long-term disease management markets in India and select international geographies through branded generics.
• Excel Division Specialty pharmaceutical division with a broader portfolio covering analgesics, anti-bacterials, anticold, antiemetic, antipyretics, cardiovascular agents, dermatologicals, gastrointestinal, and multivitamins. Includes brands such as Extacef, Blumox, Cedon, Azibest, Dolostat, Sonaderm, and Engel for acute-therapy and dermatology segments.
• MEFTAL Flagship household analgesic/antipyretic brand based on mefenamic acid; one of two brands in the IPM Top 300. Spans tablets, suspensions, drops, injections, dispersible tablets, forte variants, and antispasmodic Spas line extensions such as MEFTAL-Spas and MEFTAL-Forte. Distributed across India and exported internationally.
• TUSQ Flagship household cough & cold preparation brand; one of two brands in the IPM Top 300. Range includes TUSQ-X, TUSQ-D, TUSQ-Dx, TUSQ-LS, TUSQ-P Drops, and lozenges in liquid, drop, dispersible tablet, and lozenge dosage forms for cough, cold, and respiratory symptom relief.
• BLUMOX Amoxicillin-based anti-bacterial franchise offered as capsules, dry syrup, tablets (CA, Plus), dispersible tablets, and injections for bacterial infection management under the Excel Division.
• EXTACEF Cephalosporin antibiotic range offered as dry syrups (DS, Forte), tablets (Plus), drops, dispersible tablets, and injections (i, XL, Tazo) for bacterial infection management. Produced at the dedicated self-control Cephalosporin manufacturing unit at Nashik.
• CEDON Cefixime-based anti-bacterial line including CEDON-DS Dry Syrup, CEDON-CV tablets, CEDON-Plus, CEDON-DT, CEDON-Drops, and CEDONEX injection for bacterial infection management.
• DOLOSTAT Diclofenac-based analgesic franchise offered as tablets (SR, MR, Forte), gel (regular and Nepal pack), injection, AQ formulation, and combinations such as DOLOSTAT-SP and DOLOSTAT-PC for pain management.
• SONADERM Dermatological/topical cream range including SONADERM-GM, SONADERM-L, and SONADERM-NM creams for skin conditions under the Excel Division.
• K-Series Anti-Diabetic Range (K-Glim / K-Vog / K-Met / K-Pio / K-Gem) K-prefixed anti-diabetic range covering glimepiride (K-Glim), voglibose (K-Vog), metformin (K-Met), pioglitazone (K-Pio), and gemigliptin (K-Gem), offered as monotherapies and fixed-dose combinations (K-Glim-M, K-Glim-M-Forte, K-Glim-Trio, K-Pio-M, K-Pio-GM) for diabetes management.
• Extended Anti-Diabetic Range (Diabiz / Teneblu / Kyglip / Bluglip) Anti-diabetic franchise including DIABIZ, TENEBLU, KYGLIP, and BLUGLIP in monotherapy and fixed-dose combination variants (e.g., DIABIZ-M, DIABIZ-M Forte, DIABIZ-GM, TENEBLU-M, TENEBLU-DM, KYGLIP-M-50, BLUGLIP-M) for diabetes management under the Blue Cross Life Sciences Division.

Quantifiable outcome

• Rank 33 in Indian Pharmaceutical Market (IPM)
• +5 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

23 partnerships are on record, tiered major.

• Kanchan PharmamajorChannel Partner/ Reseller/ DistributorClearing & Forwarding (C&F) agent for Gujarat region based in Ahmedabad (B-6, Kanchan Pharma House, N.H. No 8, Aslali, Ahmedabad – 382 427). Handles Blue Cross distribution across Gujarat.
• Pharmacare Logistics Pvt LtdmajorChannel Partner/ Reseller/ DistributorC&F agent for Maharashtra region based in Bhiwandi (Bldg No. P-4, Unit No. 1/2, Prithiv Complex, Kalher Village, Bhiwandi, Thane – 421 302). Key distribution hub serving the Maharashtra market.
• Essen AssociatesmajorChannel Partner/ Reseller/ DistributorC&F agent for Tamil Nadu region based in Chennai (No 34, Gr Floor, Bay-1, Unit-3, Layon Grant Village, Vadeperubakkam, Madhavaram, Chennai – 600 066). Distributes Blue Cross products across Tamil Nadu.
• PanopharmmajorChannel Partner/ Reseller/ DistributorC&F agent for Kerala region based in Thrissur (37/1869, 37/1868, Narayananeeyam, Kottapuram Road, Poothole, Thrissur – 680 004). Handles Blue Cross distribution across Kerala.
• Pampa Logistics & ServicesmajorChannel Partner/ Reseller/ DistributorC&F agent for Karnataka region based in Hubli (May Links, #60/3, Block No.1, Upper Gr. Floor, Opp. Jain Temple, Budarsinghi, Hubballi – 580024). Distributes Blue Cross products in Karnataka.
• Padmaa Sai DistributorsmajorChannel Partner/ Reseller/ DistributorC&F agent for Telangana region based in Hyderabad (2-24-60/Part, D.No. C 8, 1st Floor, I.D.A. Uppal Khalsa(V), Uppal(M), Medchal Edchal Malkajgiri Dist., Hyderabad-500 039). Distributes Blue Cross products in Telangana.
• SB Warehousing & Logistics Pvt LtdmajorChannel Partner/ Reseller/ DistributorC&F agent for Madhya Pradesh region based in Indore (Plot No. 48, Ground Floor, SDA Annex., Lasudia Mori, Dewas Naka, Indore – 452010). Distributes Blue Cross products in MP.
• Bhasin VenturesmajorChannel Partner/ Reseller/ DistributorC&F agent for Rajasthan region based in Jaipur (59-A, Sudershanpura Ind. Area, Jaipur – 302006). Distributes Blue Cross products across Rajasthan.
• Bhattacharjee & Bros.majorChannel Partner/ Reseller/ DistributorC&F agent for West Bengal region based in Kolkata (24-B, Sura 3RD Lane, Near Baliaghata Police Station, Kolkata – 700 010). Distributes Blue Cross products in West Bengal.
• Pharma AssociatesmajorChannel Partner/ Reseller/ DistributorC&F agent for Uttar Pradesh region based in Lucknow (E-132, Transport Nagar, Lucknow Kanpur Road, Lucknow – 226 012). Distributes Blue Cross products across UP.
• Karamchand DistributorsmajorChannel Partner/ Reseller/ DistributorC&F agent for Chhattisgarh region based in Raipur (Shop No.3, Raipur C/F Market, Near R.T.O Devpuri, Raipur – 492 001). Distributes Blue Cross products in Chhattisgarh.
• Drugs IndiamajorChannel Partner/ Reseller/ DistributorC&F agent for Meerut region (51/A-1, Mohkampur Industrial Area, Phase-1, Delhi Road, Meerut – 250002). Distributes Blue Cross products in Meerut/NCR region.
• Parekh Imperial LogisticsmajorChannel Partner/ Reseller/ DistributorC&F agent for Pune region (M.No. 1236, Godown No. 1, Ground Floor, S NO 139/2,3,5, Pune Saswad Road, Uruli Devachi, PUNE- 412308). Distributes Blue Cross products in Pune.
• S.D. TradersmajorChannel Partner/ Reseller/ DistributorC&F agent for Varanasi region (Araji No. 136 KA, Bhullandpur Road, Bhullandpur PAC, Manduadih, Varanasi – 221108). Distributes Blue Cross products in Varanasi.
• MKS Commercial Private LimitedmajorChannel Partner/ Reseller/ DistributorC&F agent for Jharkhand region based in Ranchi (3RD FLR, Ramdarbar, Near Argon Battery, Tapovan, Kokar, Ranchi – 834001). Distributes Blue Cross products in Jharkhand.
• Farmanura Pte LtdmajorChannel Partner/ Reseller/ DistributorInternational C&F agent for Nepal based in Kathmandu (House of Nura, Bagh Darbar Sundhara, Kathmandu). Distributes Blue Cross products in Nepal. Tel: 00977-14-220196, 247429; Fax: 00977-14-227873.
• Raj Pharma DistributormajorChannel Partner/ Reseller/ DistributorC&F agent for Ghaziabad region (670, Basantpur Saintly, Hisali Road Industrial Area, Meerut Road, Ghaziabad – 201206). Distributes Blue Cross products in Ghaziabad.
• S.S.PharmacaremajorChannel Partner/ Reseller/ DistributorC&F agent for Punjab region based in Zirakpur (Khata No.689/710, Khasra No.19/7/2,8/2, 9/2, Under M.C. Zirakpur, Piece Godown Area, Bhabat Vill, SAS Nagar, Zirakpur-140603). Distributes Blue Cross products in Punjab.
• Shree Ganpati EnterprisemajorChannel Partner/ Reseller/ DistributorC&F agent for Patna region (Plot No. A-6 & A-7, Transport Nagar, P.O. Bahadurpur Hsg. Colony, PATNA – 800007). Distributes Blue Cross products in Bihar.
• V.R.HealthcaremajorChannel Partner/ Reseller/ DistributorC&F agent for Andhra Pradesh region based in Vijayawada (76-16-16, 1st Floor, Vankadaravari Street, Beside Reliance Supermarket, Bypass Road, Bhavani Puram, Vijayawada-520012). Distributes Blue Cross products in Andhra Pradesh.
• Adikanta AssociatesmajorChannel Partner/ Reseller/ DistributorC&F agent for Odisha region based in Cuttack (Plot No. 108/11554, 110, 144, Khata No. 247/419, P.O.-Uttampur, P.S.Sadar, Cuttack – 753012). Distributes Blue Cross products in Odisha.
• Department of Scientific & Industrial Research (DSIR), Government of IndiamajorStrategic or Co-development PartnerDSIR, under the Ministry of Science & Technology, Government of India, recognized Blue Cross Laboratories' R&D Department in 2001. The R&D facility remains DSIR-recognized, supporting scientific and innovation activities.
• Pharmacovigilance Programme of India (PvPI)majorStrategic or Co-development PartnerBlue Cross participates in India's Pharmacovigilance Programme, providing ADR reporting via toll-free 1800 123 6385 and drug safety email. References pvpi.in, ipc.gov.in, and cdsco.gov.in as authoritative regulatory sources.

Scale indicators8 records

Recent moves15 records

Expansion highlights4 records

Direct peers

• Alkem Laboratories: Indian branded-generics manufacturer of similar mid-tier scale with strong domestic presence, similar therapeutic-area mix (anti-infectives, GI, vitamins), and a comparable export footprint to emerging markets. Closest peer by business model and scale.
• Mankind Pharma: Indian mass-market branded-generics company known for household brands in similar OTC-style therapeutic areas (analgesics, cough & cold, anti-infectives, vitamins). Highly comparable business model and domestic distribution intensity.
• Ipca Laboratories: Indian pharmaceutical company focused on branded generics across anti-malarials, anti-bacterials, analgesics, and cardiovascular — overlapping therapeutic areas and similar export-to-emerging-markets orientation.
• Torrent Pharmaceuticals: Indian mid-tier pharma with strong branded-generics presence in therapeutic areas including cardiovascular, anti-diabetics, and gastroenterology — directly overlapping with Blue Cross Life Sciences Division focus.
• Glenmark Pharmaceuticals: Indian pharma company with branded generics in dermatology, anti-infectives, and respiratory care along with emerging-markets export presence. Comparable in dosage-form breadth and Indian stockist distribution.
• Cipla: One of India's largest pharmaceutical companies with strong anti-infectives, respiratory, and chronic-therapy portfolios plus extensive emerging-market exports. Direct overlap in therapeutic categories and stockist-led Indian distribution.
• Cadila Healthcare (Zydus): Indian pharma major with branded generics across cardiovascular, anti-diabetics, GI, and dermatology — directly overlapping with Blue Cross's chronic-therapy portfolio and export geography.
• Ajanta Pharma: Indian branded-generics company of similar scale with focus on anti-bacterials, anti-malarials, cardiology, and dermatology across India and emerging markets (Africa, Asia). Closely comparable business model and geographic footprint.

Broad incumbents

• Dr. Reddy's Laboratories: Larger Indian pharmaceutical major with global generic footprint including US/EU regulated markets. Operates in the same therapeutic categories but at substantially larger scale and broader geographic reach.
• Sun Pharmaceutical Industries: India's largest pharmaceutical company with a dominant branded-generics domestic franchise in chronic and specialty therapy areas. Comparable therapeutic mix but at vastly larger scale with US FDA-approved plants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blue Cross Laboratories